NASDAQ: BLTE
Belite Bio Inc Stock Ownership - Who owns Belite Bio?

Insider buying vs selling

Have Belite Bio Inc insiders been buying or selling?

No trades
There has been no insiders buying vs selling in the past 12 months.

Be the first to know when BLTE insiders and whales buy or sell their stock.

BLTE Shareholders

What type of owners hold Belite Bio Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Armistice Capital LLC0.53%167,930$10.46MInstitution
State Street Corp0.06%20,017$1.25MInstitution
Bank Of America Corp0.06%18,342$1.14MInstitution
Jpmorgan Chase Co0.05%14,636$911.82kInstitution
Ubs Group Ag0.04%12,207$760.50kInstitution
Morgan Stanley0.03%10,618$661.50kInstitution
Xtx Topco Ltd0.02%7,062$439.96kInstitution
Geode Capital Management LLC0.02%6,700$417.41kInstitution
Goldman Sachs Group Inc0.02%6,326$394.11kInstitution
Marshall Wace LLP0.02%5,865$365.39kInstitution

1 of 3

BLTE vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
BLTE0.89%0.00%
JANX62.97%37.03%Net SellingNet Buying
KNSA53.45%9.62%Net SellingNet Selling
TARS71.06%28.94%Net SellingNet Selling
VCEL91.07%8.93%Net SellingNet Selling

Belite Bio Stock Ownership FAQ

Who owns Belite Bio?

Belite Bio (NASDAQ: BLTE) is owned by 0.89% institutional shareholders, 0.00% Belite Bio insiders, and 99.11% retail investors. Armistice Capital LLC is the largest individual Belite Bio shareholder, owning 167,930.00 shares representing 0.53% of the company. Armistice Capital LLC's Belite Bio shares are currently valued at $10.32M.

If you're new to stock investing, here's how to buy Belite Bio stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.